|
News For HTWR;IRWD;OPTR;NSPH;SIA;THLD;THOR From The Last 14 Days Check below for free stories on HTWR;IRWD;OPTR;NSPH;SIA;THLD;THOR the last two weeks. |
|
|
| May 17, 2013 |
| 10:36 EDT |  | IRWD | Leerink's major/specialty pharma analyst holds analyst/Industry conference call
 Subscribe for More Information |
|
| 08:04 EDT |  | THOR | Thoratec announces FDA approval of HeartMate II Pocket Controller
Thoratec announced that it has received approval from the FDA to market the HeartMate II Pocket Controller, the small, smart, safe face of the HeartMate II LVAD System. |
|
| May 15, 2013 |
| 16:00 EDT |  | OPTR | Optimer calls active following takeover report
Optimer (OPTR) May and June 17 calls are active on 5,600 contracts (500 puts) according to Track Data. Traders are taking positions for large price movement on Cubist (CBST) offered to buy the company for $20 per share, Reuters says. |
|
| 15:54 EDT | | OPTR | Optimer up 12.5%, to $16.03 after Reuters report Cubist offered $20 per share
Subscribe for More Information |
|
| 15:53 EDT | | OPTR | Cubist offered to buy Optimer for $20 per share, Reuters says
Subscribe for More Information |
|
| 11:37 EDT | | IRWD | High option volume stocks: CONN IRWD JASO LYV CSC
|
|
| May 14, 2013 |
| 11:41 EDT | | OPTR | High option volume stocks: DANG RLGY JNY TTWO OPTR
|
|
| 09:00 EDT |  | NSPH | Nanosphere rises 15.8%
Nanosphere is up 15.8%, or 44c, to $3.23 |
|
| May 13, 2013 |
| 18:56 EDT | | NSPH | On The Fly: After Hours Movers
Subscribe for More Information |
|
| 16:53 EDT |  | OPTR | Optimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg says
Optimer (OPTR) has received first round bids from AstraZeneca (AZN), Cubist (CBST), and Astellas, reports Bloomberg, citing people familiar with the matter. Shares of Optimer spiked higher following the report, closing up $1.85, or 14.44%, to $14.66. The report notes the company disclosed almost three months ago it was exploring its strategic options. Reference Link |
| |
| 16:08 EDT | | OPTR | Optimer appoints Eric Sirota as COO
Optimer Pharmaceuticals announced the appointment of Eric Sirota as COO. Sirota has served as a consultant to the company since March 8. |
|
| 16:06 EDT | | NSPH | Nanosphere announces agreement with Hitachi High-Technologies
Subscribe for More Information |
|
| 15:56 EDT | | OPTR | Optimer jumps 13% to $14.43 after Bloomberg report on bidding process
Subscribe for More Information |
|
| 15:55 EDT | | OPTR | Optimer gets first round bids from AstraZeneca, Cubist, Bloomberg says
Subscribe for More Information |
|
| 10:58 EDT | | OPTR | High option volume stocks: PRGO OMEX SCTY OPTR DNR
Subscribe for More Information |
|
| 10:09 EDT |  | THOR | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 07:31 EDT | | THOR | Thoratec downgraded to Neutral from Buy at Lazard Capital
Subscribe for More Information |
|
| May 10, 2013 |
| 16:29 EDT |  | OPTR | On The Fly: Closing Wrap
Subscribe for More Information |
|
| 12:31 EDT | | OPTR | On The Fly: Midday Wrap
Subscribe for More Information |
|
| 11:21 EDT | | OPTR | High option volume stocks: UBNT FTK ABFS OPTR IRBT
Subscribe for More Information |
| |
|
|
|
|
